FDA Inspection 1107587 — Boehringer Ingelheim Pharma GmbH & Co. Kg
The FDA completed an inspection of Boehringer Ingelheim Pharma GmbH & Co. Kg on Aug 15, 2019 in Biberach An Der Riss. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 15, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Biberach An Der Riss (Germany)
Additional Details
Clinical BA/BE